Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
about
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentRevisiting the basic reproductive number for malaria and its implications for malaria controlAntimalarial drug resistanceNew Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus MefloquineMefloquine for preventing malaria in pregnant womenMefloquine safety and tolerability in pregnancy: a systematic literature reviewArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaArtemisinin combination therapy for vivax malariaThe benefits of artemisinin combination therapy for malaria extend beyond the individual patientAdverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaRolling back a malaria epidemic in South Africa.A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in UgandaThe role of early detection and treatment in malaria eliminationHow patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugsThe counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidenceMalaria: progress, perils, and prospects for eradicationImpact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and EthiopiaGametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient dataClinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introductionCommunity coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introductionDeployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria InitiativePrimaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunateAn open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in AsiaMalaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational studyThe Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line TherapiesMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberVivax malaria: neglected and not benignVector control in a malaria epidemic occurring within a complex emergency situation in Burundi: a case studyControlling malaria: competition, seasonality and 'slingshotting' transgenic mosquitoes into natural populations.Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesRanking malaria risk factors to guide malaria control efforts in African highlands.Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxA randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children.Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children.Evaluation of PermaNet 3.0 a deltamethrin-PBO combination net against Anopheles gambiae and pyrethroid resistant Culex quinquefasciatus mosquitoes: an experimental hut trial in Tanzania.
P2860
Q21090072-C775A21C-F15A-4196-A577-27AF82B54751Q21090219-B07F66E0-0668-4FA4-B327-137D0C4B0F5FQ22061790-2FFCE46F-E259-45EC-A8D6-F0F64EC7F131Q22061804-C664A0FB-52CC-47A6-A7E9-0CD3C5AF7F75Q24186956-36386EE0-181F-4978-BC7E-B0122CA7E950Q24599164-82955134-7F18-4EFE-97D8-2CDE54BC83B4Q24614989-3EC07804-B630-4C10-B421-2F0F35810D40Q24622539-17FA4EAF-C5AA-4B3B-86EE-7E5B9C6849DFQ24792313-5E4F66E5-593D-4271-8A50-60D4F056EB8DQ24806081-316668C5-9F8E-475C-BE19-C01786532D25Q24810617-90906E4E-A4D8-4898-8DDC-C19DDED5AEB8Q24810656-73EF4F36-A236-4191-B588-92C2BF8770B3Q24814579-3F29BAA1-281F-4908-B9D1-A5268C60BF5AQ24815752-4742F1CE-97DB-4BCB-9E76-7C6C6BDA6FE7Q26740068-2D3A6B4B-2C8B-4D30-9805-7188A8DFE635Q26823483-BC68CE05-3F60-45D2-B9C9-00C2EDCF3A06Q26828002-005B9CA6-19DB-45B2-A9FA-C1C303530EE2Q27485634-EED2F580-BDB1-40A6-AA7F-53B92F28B8D1Q27497242-0FDB15E3-0053-49B9-9E53-727C0542A1C0Q28068072-5EEC00BD-E08D-4C87-A795-9EBC6A364D9CQ28125932-A77B596B-B2C7-47B8-BA8B-A6B503E78B93Q28218629-6EBC9F97-2DCA-4A14-AE1D-600A73AD9112Q28469264-2282D49A-0339-4A55-84CC-BA04E0916AB3Q28469316-12B6AD32-FF9B-4FCE-90BC-03B8AD35E106Q28474978-014C27D8-2FB9-4A7D-96DC-427F7292808BQ28487636-7481BD78-BA11-4EAF-8BD0-1D240F8B0749Q28551049-FFD04259-AB10-4605-A775-9EA522F0712CQ29615128-2462910F-5A07-4510-A514-2D2A8FB907B1Q29619167-59CFD485-F23E-4F90-A619-C5FA26352D89Q30229482-D48884D2-828F-44A0-BC67-372695B4E566Q30420219-2B0305B3-24DB-4D02-BF09-39F05794F22EQ30492414-9E243675-96A2-4A8E-8A73-BE16CEE453D7Q30568502-553499F4-A929-4C58-8698-3EC30B5E68D2Q30928214-4E29E621-1AE0-4613-AAC5-563F156D3DECQ31118886-F188F204-62E3-4525-8D5D-EFDC75F807DDQ33251914-1C9FFCFF-A9F2-4FB9-A997-83ED5CEEB410Q33371043-CE1B14C5-FA0D-4AE5-ADB6-7E262FC3EC00Q33578910-64717885-01D8-4EE7-A0E1-DA877468CFFDQ33587420-F25267DA-F3BC-4B54-91E0-36065E70A072Q33634718-F05206C0-640A-4522-A8E1-2A6DE4D6A20D
P2860
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Effects of artesunate-mefloqui ...... Thailand: a prospective study.
@en
Effects of artesunate-mefloqui ...... Thailand: a prospective study.
@nl
type
label
Effects of artesunate-mefloqui ...... Thailand: a prospective study.
@en
Effects of artesunate-mefloqui ...... Thailand: a prospective study.
@nl
prefLabel
Effects of artesunate-mefloqui ...... Thailand: a prospective study.
@en
Effects of artesunate-mefloqui ...... Thailand: a prospective study.
@nl
P2093
P50
P921
P1433
P1476
Effects of artesunate-mefloqui ...... Thailand: a prospective study.
@en
P2093
A Brockman
C Luxemburger
M van Vugt
R McGready
P304
P356
10.1016/S0140-6736(00)02505-8
P407
P577
2000-07-01T00:00:00Z